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Abstract. The World Health Organization’s Global Program to Eliminate Lymphatic Filariasis (LF) has reduced LF
transmission worldwide, but millions remain affected by ﬁlarial lymphedema. Tools for clinically monitoring lymphedema
in developing nations are limited. We tested a novel, portable, infrared three-dimensional imaging system (3DIS) against
water displacement (WD) and tape measurement of limb circumference (TMLC) among patients with ﬁlarial leg lym-
phedema in Galle, Sri Lanka. Outcomes were accuracy and reproducibility of imaging systemmeasurements. In parallel,
we also tested the reproducibility of skin thickness ultrasound (STU)measurements.We examined 52 patients (104 limbs)
with lymphedema of stages 0–6 (N = 28, 19, 20, 21, 2, 4, and 10, respectively). 3DIS measurements correlated nearly
perfectly with WD (r2 = 0.9945) and TMLC values (r2 > 0.9801). The median time required to acquire imaging system
measurements for both legswas2.1minutes, comparedwith 17, 7, and29minutes, respectively, forWD, TMLC, andSTU.
Median interexaminer coefﬁcients of variation (CVs) for volume measurements were 1.1% (interquartile range [IQR]
0.5–2.1%) for WD and 1.7% (IQR 1.2–2.4%) for the 3DIS. CVs for circumference measurements were 1.4% (IQR
0.8–2.4%) by TMLC and 1.3% (0.8–1.9%) by 3DIS. Median interexaminer CV for STU was 13.7% (IQR 8.5–21.3%). The
portable imaging system noninvasively provided accurate and reproducible limb volume and circumference measure-
ments in approximately 2 minutes per patient. This portable technology has the potential to greatly improve assessment
and monitoring of lymphedema in the clinic and in the ﬁeld.
INTRODUCTION
Lymphatic ﬁlariasis (LF) is a debilitating, mosquito-borne, par-
asitic infection that causes hydroceles and disﬁguring lymph-
edema inmillionsof patientsworldwide.Since its initiation in2000,
the World Health Organization’s Global Program to Eliminate LF
(GPELF) has achieved remarkable success in reducing LF trans-
mission through mass drug administration (MDA),1 which has
cured millions and prevented over 80 million new infections.2
Unfortunately, MDA does not usually reverse lymphedema in
thosealreadyaffected, and there is agreat need for expandedand
improved strategies for reducing LF-related morbidity.
Efforts to study lymphedema are hampered by the difﬁculty
of measuring its severity and monitoring changes over time.
The seven-stage system of lymphedema severity developed
by Dreyer et al.3 is clinically useful, but as a noncontinuous
scale it is difﬁcult to use as an outcome in clinical trials. The
gold standard for measuring limb volume is water displace-
ment (WD),4,5 but this method is cumbersome and impractical
for use in ﬁeld studies. Tape measures of limb circumference
(TMLC) are frequently used, but can be difﬁcult to stan-
dardize and do not predict volume adequately for lower
extremity lymphedema.6,7 Ultrasound can be used to measure
the thickness of skin and soft tissues over the malleolus (skin
thickness ultrasound [STU]),8 but this method requires expen-
sive equipment and adequate training, and it is difﬁcult to
standardize.
Three-dimensional (3D) optical imaging is a promising new
technology for lymphedema measurement and monitoring.
An opto-electronic device called Perometer® (Pero-System
Messgeraete, Wuppertal, Germany) was the ﬁrst infrared-based
system developed for limb geometry measurement and
has been used to monitor lymphedema.9 Other tech-
niques using stereophotogrammetry and infrared struc-
tured light depth sensors from XBOX Kinect™ (Microsoft
Corporation, Redmond, WA) have also been reported.10–13
However, these techniques are limited by large hardware
requirements and/or limited accuracy, and this has pre-
vented their widespread use. Recently, LymphaTech, Inc.
(Atlanta, GA) developed a novel lymphedemameasuring and
monitoring tool that uses a 3D infrared depth sensor in-
tegrated into a computer tablet with custom software. Given
the need for improvedmethods ofmeasuring lymphedema in
ﬁlariasis patients, we tested this technology in patients with
ﬁlarial lower extremity lymphedema to determine whether it
could produce accurate and reproducible limb geometry
measurements suitable for monitoring disease progression
or improvement over time.
MATERIALS AND METHODS
Ethics statement. The study protocol was reviewed and
approved by the institutional review board at the Washington
University School of Medicine and the Ethical Review Com-
mittee, Faculty of Medicine, University of Ruhuna in Sri Lanka.
Printed participant information sheets and written consent
forms were provided to participants in Sinhalese. Written
consent was obtained from all participants who were eligible
for this study (age ³ 18 years).
Patient population and setting. Volunteers with varying
stages of limb lymphedema were recruited from among those
receiving care at the Filariasis Research Training and Service
Unit (FRTSU), Faculty ofMedicine, inGalle, Sri Lanka. Patients
were contacted by mail or phone and offered the opportunity
to participate. Interested patients presented to the FRTSU
clinic between March 20 and 31, 2017, for enrollment and
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measurements. Adults with any stage of lymphedema were
eligible to participate.
Study procedures. Six examiners were trained to perform
WD, TMLC, STU, and 3D imaging system (3DIS) lymphedema
measurements during the ﬁrst 2 days of the study period
(March 20–31, 2017) with nine patient volunteers. Training day
measurements were not included in the data analysis. Study
measures and examination methods are shown in Table 1.
TMLC, STU, and 3DIS measures were performed by three
separate examiners per patient. WD was performed twice per
patient, as we found it impractical to perform thrice per patient
during the trainingperiod. Examiners recorded a start time and
stop time for each examination so that the cumulative time
needed for each could be reported. In this article, we deﬁne an
“examination” as the measurement of both legs from one
patient by one examiner. However, most patients with unilat-
eral lymphedema had only the affected limb (stages 1–6) ex-
aminedbySTU. In suchcases, theexamination time forSTUof
one limb was doubled to provide a time estimate for a
complete (bilateral) examination.
WDwasmeasured using a rectangular water tank ﬁttedwith
a drainage spout at a height of 32 cm above the inner base of
the tank. The tank was ﬁlled until water drained from the spout
and was allowed to drip to cessation. The patient placed his/
her leg inside adisposable, transparent, watertight cellophane
bag and immersed the leg in the tank (Figure 1C). The patient
stood with the knee of the measured limb straight until
water stoppeddripping from the spout. Patientswith trouble
balancing could hold a nearby countertop for support. The
displaced water volume was measured using standard
graduated cylinders (2 L, 500mL, or 250mL). This procedure
was performed on both legs of each patient by two in-
dependent examiners. Start time for WD began after the
water tank had equilibrated, and examination duration in-
cluded the time it took tomeasure the ﬁrst leg, re-equilibrate
the tank, and thenmeasure the second leg. Some examiners
also included the time it took to reset the tank after mea-
surement of the second leg (completing the cycle), but this
was not uniformly done, so the mean examination times
reported represent at least the time taken to measure both
legs and reset the tank once, but less than the complete
cycle time.
TMLC was measured around the foot at 10 cm proximal to
thegreat toe andaround the leg at heights of 12, 24, and36cm
above the ﬂoor while the patient sat with the knee directly
above the ankle.14 For the foot measurement, a line on the
surface on which the foot rested marked 10 cm from the tip of
the great toe. The examiner marked the medial and lateral
sides of the foot where they crossed this line and then aligned
a tape measure to those markings to measure the circumfer-
ence. For the leg measurements, a height pole positioned
parallel to the leg from the knee to the ankle malleolus was
used tomark the correct height on themedial and lateral sides
of each leg (Figure 1B), and circumference was measured by
positioning a tape measure around the marks. Three exam-
iners independentlymeasuredeach leg; themarkswerewiped
off the skin between each examination.
Ankle STU measurements were performed essentially as
described by Mand et al.,8 using a linear transducer (L12-4,
Phillips Healthcare, Bothel, WA) connected to an 8-inch S2
tablet (Samsung Electronics America, Inc., Ridgeﬁeld Park,
NJ) equipped with the downloadable Phillips Lumify app
(Phillips Healthcare). The patient sat or reclined on an exami-
nation table with the knee extended and the toes pointing
upward. Holding the transducer parallel to the table and per-
pendicular to the leg, the examiner located the malleolus by
scanning along the leg to the narrowest distance between the
skin surface and the tibia (medial) or ﬁbula (lateral) (Figure 1A).
The examiner then brought the tendon sheath posterior to the
malleolus into view (tibialis posterior on the medial side, pe-
roneal tendon sheath on the lateral side); with this marker in
view, the examiner captured the image and measured the
distance between the skin surface and themalleolus using the
software calipers. Each examiner took four measurements
over each malleolus (repositioning the probe and capturing a
new image each time to give independent measurements),
and each patient was examined by three separate examiners.
For each site, the four measures of each individual examiner
were compared to determine intraobserver variability. The
individual measures were then averaged and the averages
TABLE 1








Examiners per participant 2 3 3 3
Examinations per participant per examiner 1 1 1 2
Total examinations per patient 2 3 3 6
Number of measurements per examination
Leg volume (ﬂoor to 32 cm height) 1 – – 1
Circumference measurements
Foot (10 cm from the tip of the great toe) – 1 – –
Leg, 12 cm height – 1 – 1
Leg, 24 cm height – 1 – 1
Leg, 36 cm height – 1 – 1
Skin thickness over the malleolus
Left lateral – – 4 –
Left medial – – 4 –
Right medial – – 4 –
Right lateral – – 4 –
Intraexaminer comparison* No No Yes Yes
Interexaminer comparison† Yes Yes Yes Yes
* For STU, variability among the four replicate measurements at each site was assessed; for the 3D imaging system variability between the ﬁrst and second examinations of each examiner.
†The four replicate measurements for each STU examination were averaged and the mean was compared between examinations. All 3D imaging system measurements for each patient,
regardless of examiner, were included.
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from each of the separate examiners compared to determine
interobserver variability. Because of the time burden of per-
forming STU, we did not perform STU on most stage 0 (un-
affected) limbs.
The 3DIS (LymphaTech) combines an infrared depth sensor
with a tablet computer using proprietary software. The system
integrates 3D depth data acquired from the sensor with ac-
celerometer data from the tablet to perform real-time point
cloud fusion, producing complete point cloud reconstructions
with submillimeter resolution. Custom software extracts spe-
ciﬁc limb volume and circumference measurements. The 3DIS
procedure starts with the patient standing in the center of an
open space with his/her feet approximately shoulder-width
apart. The examiner stands 2–3 feet away from the patient and
points the tablet camera at the patient’s legs. A sizing box
superimposed on the tablet screen’s live camera view is ad-
justed to set the data capture window for the depth sensor. As
the examiner walks in a circle around the standing patient to
capture visual data (Figure 1D, Supplemental Video 1), the
tablet screen shows a 3D model acquisition overlaid on the
image of the leg so that the examiner can verify adequate data
capture. The examiner ensures that the entire surface of both
legs is captured, then stops data capture and views the 3D
reconstruction of the patient’s limbs, rotating the image to en-
sure it contains no gaps or artifactual distortions (Figure 2). For
this study examiners captured data from just above a patient’s
knees to the ﬂoor, and the imaging system software calculated
limb volume from the ﬂoor to a height of 32 cm and leg cir-
cumference measurements at heights of 12, 24, and 36 cm,
from the 3D model. Each patient was imaged twice by each of
three separate examiners. An example of the 3D point-cloud
model generated by the imaging system can be viewed online
(Supplemental Video 2).
Data capture and analysis. WD, STU, and TMLC mea-
surementswere recorded on paper forms and transcribed into
an MS Excel database. Transcribed data were independently
checked against the primary data forms by a second reviewer.
3DIS data were electronically transferred to MS Excel. All
analyses were performed in Stata, version 12.1 (College Sta-
tion, TX). Means and standard deviations are reported for data
that were normally distributed (skew between −1.0 and 1.0).
Medians and interquartile range (IQR) are reported for skewed
data. Because most data were not normally distributed, we
used the Kruskal–Wallis test and the Wilcoxon rank-sum test
to determine statistical signiﬁcance for group or pairwise com-
parisons, respectively. Replicate measurements from each ex-
aminer were averaged and compared across examiners to
generate interexaminer coefﬁcients of variation (CVs).
RESULTS
Fifty-two patients with varying stages of lymphedema were
examined. The median time required to acquire 3DIS mea-
surements of both legs was 2.1minutes, comparedwith 17, 7,
and 29 minutes, respectively, for WD, TMLC, and STU
(Table 2).
Accuracy of 3DIS. Limb volume and circumference mea-
surements obtained by 3DIS were highly accurate and tightly
correlated with WD and TMLC measurements (r2 > 0.98,
Figure 3). Linear regression correlation coefﬁcients (and 95%
conﬁdence intervals) obtained by comparing 3DIS estimates
withmeanWD and TMLCmeasurements at 12, 24, and 36 cm
heights were 1.02 (1.01–1.02), 0.99 (0.98–0.99), 0.97
(0.96–0.98), and 0.95 (0.94–0.97), respectively. A coefﬁcient of
1.00 would indicate exact agreement between 3DIS and
comparator measurements.
Intraexaminer variability. Intraexaminer CVs for 3DIS
measurements ranged from 0% to 4.9% and varied by ex-
aminer and lymphedema stage. Median CVs for 3DIS volume
measurements (1.1%, IQR 0.5–2.1%) were somewhat higher
than those for 3DIS circumference measurements (0.8%,
IQR 0.4–1.3%; P < 0.001). Intraexaminer CVs for STU ranged
FIGURE 1. Studymeasurements: (A) skin thicknessultrasound, (B) limbcircumference, (C) water displacement volume, and (D) three-dimensional
imaging system. This ﬁgure appears in color at www.ajtmh.org.
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from 0.2% to 39.9%, with a median of 4.8% (IQR 2.9–8.0%),
and also varied by examiner and lymphedema stage
(Supplemental Table 1). Because WD and TMLC were
measured only once per examiner per patient, no intra-
examiner comparisons for these measurements were
possible.
Interexaminer variability. Interexaminer variability for all
methods is shown in Figure 4.Median interexaminer CVswere
not signiﬁcantly different between the 3DIS and TMLC mea-
surements at 12 cm and 36 cm, but they were lower at 24 cm
for the 3DIS (1.3%, IQR 0.8–1.9%) than for TMLC measure-
ments (2.0%, IQR 1.0–3.1%; P = 0.0001). CVs for TMLC at
24 cm were also slightly but signiﬁcantly higher than each of
the other TMLC measurements (Supplemental Table 2). Me-
dian interexaminer CVs for TMLC of the foot was 1.2% (IQR
0.7–2.0%), but this could not be comparedwith 3DIS because
the imaging system software could not provide foot circum-
ference measurements. For limb volume measurements,
median interexaminer CVs for the 3DIS (1.7%, IQR 1.2–2.4%)
were slightly higher than for WD (1.2%, IQR 0.5–2.1%; P =
0.0001). In no interexaminer comparison did the 3DIS CV ex-
ceed 6%, whereas some CV values exceeded 10% for all
other measures. STU was the only modality for which inter-
examiner variability differed by stage (Supplemental
TABLE 2
The number of patients and limbs examined, and time required per examination
Water displacement
(WD)






Patients examined 49 49 52 49
Total limbs examined 98 98 74 98
Stage of examined limbs
Stage 0 26 26 1 26
Stage 1 18 18 19 18
Stage 2 20 20 20 20
Stage 3 19 19 21 19
Stage 4 2 2 2 2
Stage 5 3 3 4 3
Stage 6 10 10 7 10
Total examinations performed* 94 147 154 287
Number of examinations timed 92 145 152 268
Minutes required per examination,
median (IQR)†
17 (14.5–20) 7 (6–8) 29 (25–34) 2.1 (1.7–2.4)
IQR = interquartile range.
* Not all patients completed all intended examinations; four patients declined a second WD examination, four patients received only two (rather than three) STU examinations because of time
constraints, and fourpatientshadoneormore3DISexaminationsunintentionally skippedby thestudy team (onepatient received3of 6, one4of 6, and two5of 6). ForSTU,70examinations included
both legs and 84 included only one because most unaffected (stage 0) limbs were not measured by STU.
†For STU examinations that included only one leg, the examination time was doubled so that all values approximate the time required to measure both legs.
FIGURE 2. Reconstructions createdby the three-dimensional (3D) imaging system. (A) Photos and imaging system reconstructions frompatients
with different stages of lymphedema. (B) One patient’s point-cloud reconstruction, demonstrating how the model can be rotated and analyzed for
circumference measures. A video of a rotating 3D model showing the level of detail captured can be viewed online (Supplemental Video 2). This
ﬁgure appears in color at www.ajtmh.org.
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Table 2), with stages 5 and 6 having signiﬁcantly lower
CVs than stages 0–4 (median 9.2% versus 15.2%, P =
0.0004). A linear regression of interexaminer CV versus
mean skin thickness conﬁrmed that STU was signiﬁcantly
less variable at greater skin thicknesses (regression
coefﬁcient −4.0, 95% conﬁdence interval −6.1 to −1.9).
DISCUSSION
While much of the attention of GPELF has focused on re-
ducing LF transmission throughMDA, the program also aims
to improve morbidity management for persons with clinically
evident ﬁlariasis. The latter activity will last long after trans-
mission of the infection has been interrupted. Improved
methods for assessing and monitoring changes in ﬁlarial
lymphedema are needed to improve clinical management of
patients and for clinical trials that assess the impact of new
treatments or management strategies. In addition, methods
capable of reliably detecting small volume changes might
help identify patients needing therapy earlier, preventing
progression to advanced disease. A major study docu-
mented an impressive regression of lymphedema in some
ﬁlariasis patients after doxycycline treatment,8 and addi-
tional studies are planned to conﬁrm this important ﬁnding
(ClinicalTrials.gov Identiﬁers: NCT02929134, NCT02927496,
NCT02929121). Part of the motivation for the current study
came fromadesire to use the best possible outcomemeasures
in these trials.
Each examination method used in our study had different
strengths andweaknesses.WDwas themost reliable but also
the slowest method assessed; it was also difﬁcult to use in
patientswith advanced lymphedema. Somepatientswith very
large limbs required assistance to lift their leg into the tank, and
occasionally water spilled from the tank that could not be
measured. Patients also had difﬁculty standing still for the
several minutes it took for water to completely drain from the
tank during limbmeasurement. As a result, three patients with
stage 5 or 6 lymphedema in our study could only tolerate a
single WD examination. The time required to reset the tank
after each examination also contributed to the long exami-
nation times.
TMLC was easier for the patients but less reliable than
WD, and it was relatively labor and time intensive. The use of
a pole to mark height measurements on both the medial
and lateral sides of each leg increased reproducibility and
decreased the risk ofmeasuring oblique circumferences. As
expected, irregular contours seem to increase the difﬁculty
of obtaining reproducible measurements. TMLC was sta-
tistically less reliable at the 24 cm height, a height at which
the curvature of the calf muscle is prominent. In addition, the
highest outliers were seen among foot circumference
measurements, presumably because the irregular anatomy
of the foot makes it difﬁcult to ensure that the measurement
is performed at the same angle and at exactly 10 cm from the
tip of the great toe each time.
FIGURE 3. Correlation of three-dimensional imaging system mea-
surements with water displacement (A) or with tape measurements of
limb circumference (TMLC) at heights of 12 cm (B), 24 cm (C), and 36
cm (D). Gray shading around the regression line indicates 95% con-
ﬁdence intervals for the regression. This ﬁgure appears in color at
www.ajtmh.org.
FIGURE 4. Interexaminer variability for each examination method is
shown in Panel A. Panel B compares variability obtained with the
three-dimensional imaging system (3DIS) (in green) with variability
observed with tape measures of limb circumference (TMLC) at dif-
ferent levels and water displacement (WD) (orange). The two highest
CV outliers for TMLC shown in panel A were foot measurements.
Therewasno3DIScomparison for thisTMLCmeasurementand that is
why this comparison is not shown in panel B. STU = skin thickness
ultrasound. This ﬁgure appears in color at www.ajtmh.org.
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STU was the most difﬁcult method to standardize. None of
the examiners were trained radiologists or ultrasound tech-
nicians. Although a standard operating procedure (SOP) was
taught, it did not address every contingency, especially for
patients with atypical anatomy. The higher interexaminer
versus intraexaminer variability suggests that examiners de-
veloped their own habits for dealing with these uncertainties.
In addition, examiners were not blinded to their own replicate
measurements and may have been biased to obtain replicate
values that matched their initial measurement. By contrast,
examiners were blinded tomeasurements of other examiners,
making interobserver variability amoremeaningful outcome in
our study. Probe positioning habits likely contributed to high
interexaminer variability. For example, examiners were taught
to deliberately decompress the skin after ﬁnding the STU
markers, but it is difﬁcult to know how effectively this was
done. Improved training, amore comprehensive SOP, and the
use of formally trained ultrasonographers would likely reduce
STU variability, but this would also make it less practical for
use in resource-limited settings.
The infrared 3DIS had several advantages and few limita-
tions compared with the other methods studied. It was es-
sentially equivalent to TMLC andWD in terms of accuracy and
reproducibility, but much faster, providing volume and cir-
cumference measurements for both legs in less than one-
tenth of the combined time required for WD and TMLC. The
3DIS does not require physical contact with the patient, which
is important for patients with skin ulcers or infected wounds
that are common in patients with advanced lymphedema. To
reduce the risk of infection and contamination of equipment,
we did not obtain TMLC or STU measurements over open
wounds, and we used disposable plastic bags to cover limbs
during WD. None of these precautions were necessary for 3D
imaging. The primary limitation of the 3DIS in our study was
that image-derived circumference measurements at the
36 cm height had to be discarded for four patients whose
clothing obscured the leg surface (the examiner failed to en-
sure that the patient’s legswere bare up to the knee). Similar to
WD, the 3DIS requires that patients stand still to obtain ac-
curatemeasurements, but this limitation is offset by the speed
of the process and by software that prompts the examiner to
abort and restart the examination if patient movements are
detected. Although each patient was imaged twice by each of
the three examiners, no patients in our study declined imaging
because of difﬁculty in tolerating the procedure.
One potential limitation of the 3DIS for widespread use in
ﬁlariasis is cost. It is not clear what the cost of the system will
be once the manufacturer brings the device to market, but the
total cost of the hardware (computer tablet, infrared sensor)
used in this study was approximately $1,300, which does not
include software development and licensing costs or support.
Assuming that the market price will be higher than the hard-
ware costs, it may be difﬁcult for clinics in extremely resource-
limited settings to acquire a system without external support.
On the other hand, the current cost is relatively low compared
with that of other clinical laboratory technologies. It may also
be possible to further reduce costs if the system software can
be modiﬁed for use on personal tablets or smartphones and
distributed through an app store. Another limitation of the
3DIS in this study was the inability to take foot circumfer-
ence measurements. This is because the manufacturer had
not yet created software algorithms for extrapolating foot
circumference measurements, although such software is in
development. Given the accuracy of the imaging system’s
volume measurements, which include the volume of the
foot, it seems highly likely that accurate foot circumference
and/or dedicated foot volume measurements should also
be possible with updated image processing code. Although
the lack of dedicated foot measurements was a limitation of
3DIS measurements for this study, it also illustrates the
ﬂexibility of the technique. Once the point-cloud model is
acquired, it requires only the appropriate software code to
extrapolate any number of potential additional measure-
ments. In this study, we chose to extrapolate leg volume
with a cutoff of 32 cm height and circumference measure-
ments at 12, 24, and 36 cm height to match the WD and
TMLC measurements. In future studies, however, any num-
ber of circumference or volume measurements might be
extracted, including foot circumference, breadth, and height of
the foot dorsum, etc., with appropriate modiﬁcation of the
scanner software currently under development.
To our knowledge, this is the ﬁrst time that infrared 3D imaging
technology has been used in patients with ﬁlarial lymphedema,
and the results are highly encouraging. The 3DIS provided esti-
mates of limb volume and circumference that were highly corre-
lated with global standard methods (WD and TMLC) for patients
with a wide range of limb sizes and varying stages of lymphe-
dema. The intra- and interexaminer variability for 3DIS measure-
mentswere very low and comparable with those observedwith
WD. However, 3D imaging is much faster andmore feasible for
use in clinical or ﬁeld settings than WD, particularly when one
considers that a single 2- to 3-minute scan can generate both
volume and any desired circumferencemeasurements. Ninety-
ﬁve percent of interexaminer comparisons for the 3DIS had CV
values less than 3.3%, and all were less than 6%, suggesting
that this technology should be able to reliably detect true
changes in limb volume or circumference of 6% ormore with a
high degree of conﬁdence. Although these results require
conﬁrmation, it appears that this novel 3D imaging technology
will greatly improve our ability to accurately assess andmonitor
changes in leg lymphedema over time in the clinic and in the
ﬁeld.
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